Spots Global Cancer Trial Database for neoplasm
Every month we try and update this database with for neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase II Trial for Large ER-Negative Breast Cancers | NCT01869192 | Malignant Neopl... | Epirubicin Cyclophosphamid... Docetaxel Capecitabine Radiation Thera... | 18 Years - | University of Colorado, Denver | |
| Study of TRC102 in Combination With Pemetrexed in Cancer Patients | NCT00692159 | Neoplasm | TRC102 + pemetr... | 18 Years - | Tracon Pharmaceuticals Inc. | |
| Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer | NCT00496236 | Head and Neck C... Head and Neck N... | TNFerade biolog... | 18 Years - | GenVec | |
| Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer | NCT00496236 | Head and Neck C... Head and Neck N... | TNFerade biolog... | 18 Years - | GenVec | |
| A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma | NCT00523640 | Carcinoma, Rena... | combination of ... | 18 Years - | University of Chicago | |
| A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors | NCT02440685 | Lymphoma, Large... Lymphoma, Mantl... Lymphoma, Folli... Cancer Neoplasm Tumor Lymphoma, Malig... Lymphoma, B-cel... Lymphoma, Non-H... B-Cell Chronic ... B-Cell Leukemia... B-Lymphocytic L... Chronic Lymphoc... Leukemia, Lymph... Leukemia, Lymph... Myelofibrosis Chronic Idiopat... Idiopathic Myel... Lymphoma, T Cel... Peripheral T-Ce... T-Cell Lymphoma... | ASN002 Dose Esc... ASN002 RD | 18 Years - | Asana BioSciences | |
| Thoracic OncoGeriatric Assessment (TOGA) Trials | NCT00591981 | Thoracic Neopla... Lung Neoplasms Esophagus Neopl... Pleural Neoplas... Thymus Neoplasm... | TOGA Tools | 70 Years - | University of Wisconsin, Madison | |
| Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002) | NCT01092091 | Neoplasm Hepatocellular ... | Pegylated Recom... | 18 Years - 75 Years | Bio-Cancer Treatment International Limited | |
| Linkage of Medicaid Enrollment Information to Surveillance, Epidemiology and End Results Data | NCT02875327 | Neoplasm Health Services... Outcome Assessm... Healthcare Disp... | 1 Year - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| Epidemiological Study of Colorectal Cancer in WuHan | NCT01863303 | Diarrhea Constipation Melena Neoplasm Colonic Neoplas... Pain | 40 Years - 74 Years | Wuhan Pu-Ai Hospital | ||
| A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer | NCT02747342 | Neoplasm Prostate Cancer | SHR3680; SHR316... | 18 Years - | Atridia Pty Ltd. | |
| Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo | NCT01512173 | Infantile Heman... | propranolol gel Placebo | 35 Days - 150 Days | Pierre Fabre Dermatology | |
| A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors | NCT02605083 | Cancer | eFT508 | 18 Years - | Effector Therapeutics | |
| Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease | NCT01819766 | Inflammatory Bo... Primary Scleros... Colorectal Neop... Colorectal Canc... | 18 Years - 84 Years | Exact Sciences Corporation | ||
| Assesment of the Implementation of a Therapeutic Educational Intervention Affecting Adherence to Oral Chemotherapy | NCT02828449 | Neoplasm | therapeutic edu... | 18 Years - | Institut de Cancérologie de la Loire | |
| Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain Metastases | NCT02265549 | Metastases, Neo... | 18 Years - | Maastricht Radiation Oncology | ||
| A Phase II Study of Spinal Radiosurgery | NCT00573872 | Neoplasm Arteriovenous M... | Radiosurgery | 19 Years - | University of Alabama at Birmingham | |
| Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies | NCT01260168 | Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | 40 Years - 90 Years | Exact Sciences Corporation | ||
| Improving Health Behaviors for Pediatric Cancer Survivors | NCT04097353 | Cancer | Harvesting Hope... Surviving Stron... | 8 Years - 12 Years | Nationwide Children's Hospital | |
| A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma | NCT00523640 | Carcinoma, Rena... | combination of ... | 18 Years - | University of Chicago | |
| A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer | NCT01616303 | Ovarian Neoplas... | Carboplatin Paclitaxel oregovomab | 18 Years - 75 Years | Quest PharmaTech Inc. | |
| Assesment of the Implementation of a Therapeutic Educational Intervention Affecting Adherence to Oral Chemotherapy | NCT02828449 | Neoplasm | therapeutic edu... | 18 Years - | Institut de Cancérologie de la Loire | |
| A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 | NCT03058289 | Breast Cancer Head and Neck C... Squamous Cell C... Lymphoma Pancreatic Canc... Liver Cancer Colon Cancer Lung Cancer Bile Duct Cance... Chordoma of Sac... Sarcoma | INT230-6 anti-PD-1 antib... anti-CTLA-4 ant... | 18 Years - | Intensity Therapeutics, Inc. | |
| A Study of PSB205 in Subjects With Advanced Solid Tumors | NCT03986606 | Neoplasm Malign... | PSB205 | 18 Years - | Qilu Puget Sound Biotherapeutics (dba Sound Biologics) | |
| A Study of Galunisertib on the Immune System in Participants With Cancer | NCT02304419 | Neoplasm | Galunisertib | 18 Years - | Eli Lilly and Company | |
| Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer | NCT00080418 | Neoplasm | Liposome Entrap... | 18 Years - | INSYS Therapeutics Inc | |
| I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer | NCT01042379 | Breast Neoplasm... Breast Cancer Breast Tumors Angiosarcoma TNBC - Triple-N... HER2-positive B... HER2-negative B... Hormone Recepto... Hormone Recepto... Early-stage Bre... Locally Advance... | Standard Therap... AMG 386 with or... AMG 479 (Ganitu... MK-2206 with or... AMG 386 and Tra... T-DM1 and Pertu... Pertuzumab and ... Ganetespib ABT-888 Neratinib PLX3397 Pembrolizumab -... Talazoparib plu... Patritumab and ... Pembrolizumab -... SGN-LIV1A Durvalumab plus... SD-101 + Pembro... Tucatinib plus ... Cemiplimab Cemiplimab plus... Trilaciclib wit... SYD985 ([vic-]t... Oral Paclitaxel... Oral Paclitaxel... Amcenestrant Amcenestrant + ... Amcenestrant + ... ARX788 ARX788 + Cemipl... VV1 + Cemiplima... Datopotamab der... Datopotamab der... Zanidatamab Lasofoxifene Z-endoxifen ARV-471 ARV-471 + Letro... | 18 Years - | QuantumLeap Healthcare Collaborative | |
| A Study of LY2835219 in Participants With Cancer | NCT02117648 | Neoplasm Neoplasm Metast... | Abemaciclib Clarithromycin | 18 Years - | Eli Lilly and Company | |
| Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype | NCT00001572 | B Cell Lymphoma Follicular Lymp... Neoplasm | Id-KLH Vaccine QS-21 (Stimulat... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Impact of Anesthesia Maintenance Methods on Long-term Survival | NCT02660411 | Aged Neoplasms Surgical Proced... Anesthesia, Inh... Anesthesia, Int... Survival | Sevoflurane Propofol | 65 Years - 90 Years | Peking University First Hospital | |
| Tissue Acquisition for Molecular Diagnostics | NCT00001580 | Neoplasm | - | National Institutes of Health Clinical Center (CC) | ||
| Effects of Laugh-yoga Intervention on Mood and Quality of Life Among Oncologic Patients in a Oncologic Clinic Setting. | NCT01156935 | Neoplasms | Laugh Yoga | 18 Years - 90 Years | Wolfson Medical Center | |
| A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. | NCT00199836 | Cancer Neoplasm | NY-ESO-1b pepti... | 18 Years - | Ludwig Institute for Cancer Research | |
| Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits | NCT00001500 | Acquired Immuno... Alcoholism HIV Infection Neoplasm Smoking | - | National Institutes of Health Clinical Center (CC) | ||
| Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062) | NCT03099161 | Neoplasm | preladenant pembrolizumab | 18 Years - | Merck Sharp & Dohme LLC | |
| Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer | NCT01397747 | Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | 50 Years - 84 Years | Exact Sciences Corporation | ||
| Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls | NCT02450175 | Neoplasm | Everolimus Letrozole | 18 Years - | Sinai Hospital of Baltimore | |
| A Phase II Study of Spinal Radiosurgery | NCT00573872 | Neoplasm Arteriovenous M... | Radiosurgery | 19 Years - | University of Alabama at Birmingham | |
| ECI301 and Radiation for Advanced or Metastatic Cancer | NCT01441115 | Cancer Neoplasm Metast... Radiation Oncol... Neoplasm Metastasis | Radiation Thera... ECI301 | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| A Phase II Study of Spinal Radiosurgery | NCT00573872 | Neoplasm Arteriovenous M... | Radiosurgery | 19 Years - | University of Alabama at Birmingham | |
| A Study of ABT-165 in Subjects With Solid Tumors | NCT01946074 | Advanced Solid ... | paclitaxel FOLFIRI ABT-165 ABBV-181 | 18 Years - 99 Years | AbbVie | |
| Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo | NCT01512173 | Infantile Heman... | propranolol gel Placebo | 35 Days - 150 Days | Pierre Fabre Dermatology | |
| Utilization of Genomic Information to Augment Chemotherapy Decision-making for People With Incurable Malignancies | NCT01802905 | Advanced Incura... | in depth genomi... | 18 Years - | British Columbia Cancer Agency | |
| Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer | NCT00026897 | Neoplasm | Gamma-camera im... Low-risk biopsy | - | National Institutes of Health Clinical Center (CC) | |
| Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls | NCT02450175 | Neoplasm | Everolimus Letrozole | 18 Years - | Sinai Hospital of Baltimore | |
| Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies | NCT01117623 | Neoplasm | Escalation coho... Escalation coho... Escalation coho... Escalation coho... Escalation coho... HCC Child-Pugh ... HCC Child-Pugh ... NSCLC expansion... | 18 Years - | Bayer | |
| Evaluating Biobanking Educational Tools | NCT01672944 | Neoplasm | TBCCN-developed... NCI-developed e... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| The Physical Exercise and Prostate Cancer Study | NCT00658229 | Prostate Cancer | Strength traini... | - 75 Years | Oslo University Hospital | |
| Natural History of and Specimen Banking for People With Tumors of the Central Nervous System | NCT02851706 | Brain Cancer Brain Tumor Spine Cancer Spine Tumor Neoplasm | No Treatment | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin | NCT03388190 | Colorectal Canc... | Nivolumab FLOX | 18 Years - | University Hospital, Akershus | |
| A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme | NCT05053880 | Recurrent Gliob... | ACT001 ACT001 + Pembro... | 18 Years - | Accendatech USA Inc. | |
| A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning | NCT00026936 | Neoplasm | Radiotherapy | - | National Institutes of Health Clinical Center (CC) | |
| Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors | NCT05013554 | Neoplasm Malign... Breast Cancer Lung Neoplasm M... Gastric Cancer Neoplasm | SAR443216 IV SAR443216 SC | 18 Years - | Sanofi | |
| Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca | NCT00756132 | Locally Advance... Breast Cancer | 18 Years - 65 Years | University Health Network, Toronto | ||
| Nursing and Pharmacy Time for Delivering Xeloda® Versus 5-Fluoruracil Regimens | NCT01801085 | Colorectal Canc... | 18 Years - | Chinese University of Hong Kong | ||
| Gorbly Compression Device for Use in Image-guided Procedures | NCT02578667 | Neoplasm Sepsis | Gorbly Compress... | - | University of Miami | |
| Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms | NCT00408018 | Neoplasm | P276-00 | 18 Years - | Piramal Enterprises Limited | |
| Cancers Treated With Combination of Antrodia Cinnamomea and Chemotherapy | NCT01287286 | Neoplasm Functional Gast... | AC-Can placebo | 18 Years - 80 Years | Chang Gung Memorial Hospital | |
| A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid Tumors | NCT02099058 | Advanced Solid ... | Osimertinib Nivolumab Telisotuzumab v... Telisotuzumab v... Erlotinib | 18 Years - | AbbVie | |
| The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation | NCT03181334 | Colorectal Canc... | Branch I Branch II Branch III Branch IV Branch V | 50 Years - 74 Years | University of Texas Southwestern Medical Center | |
| Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms | NCT00160472 | Ovarian Neoplas... | removal of ovar... | 18 Years - | Tripler Army Medical Center | |
| Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN) | NCT01104077 | Pancreatic Canc... Neoplasm | 18 Years - 85 Years | Columbia University | ||
| The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial | NCT05101798 | Neoplasm Skull Base Neop... | 5-Aminolevulini... | 18 Years - 80 Years | Icahn School of Medicine at Mount Sinai | |
| Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases | NCT00434317 | Neoplasm Metast... | Zoledronic acid | 18 Years - | Novartis | |
| Current Practice Pattern and Effect of Training in Upper Endoscopic Biopsy | NCT02044536 | Neoplasm | No intervention | - | Chuncheon Sacred Heart Hospital | |
| Behavioral Coaching Intervention (Laguna Health) for Patients With Cancer | NCT06004141 | Cancer | Laguna Health | 18 Years - | Massachusetts General Hospital | |
| Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies | NCT01117623 | Neoplasm | Escalation coho... Escalation coho... Escalation coho... Escalation coho... Escalation coho... HCC Child-Pugh ... HCC Child-Pugh ... NSCLC expansion... | 18 Years - | Bayer | |
| A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck Cancer | NCT00496535 | Head and Neck C... Head and Neck N... | TNFerade biolog... | 18 Years - | GenVec | |
| EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer | NCT00035100 | Ovarian Neoplas... Peritoneal Neop... Fallopian Tube ... | epothilone b | 18 Years - | Novartis | |
| Endobronchial Ultrasound Guided Transbronchial Lung Biopsy With or Without Guide Sheath in Lung Tumors and the Analysis of Echoic Patterns of Lung Tumors and Mediastinal Lymph Nodes, and the Association Between Diagnostic Yield of Transbronchial Lung Biopsy and EBUS Echoic Features. | NCT00415337 | Lung Neoplasms | endobronchial u... | 18 Years - | Chang Gung Memorial Hospital | |
| Role of the Pharmacist in Detection of Drug Interactions Before Antitumor Treatment Initiation | NCT04142567 | Neoplasm | 18 Years - | Assistance Publique - Hôpitaux de Paris | ||
| Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age | NCT03177863 | CIN2 Therapy | Expectancy | 25 Years - 30 Years | Sahlgrenska University Hospital, Sweden | |
| Primary Progesterone Therapy for Operable Breast Cancer | NCT00123669 | Breast Neoplasm... | 500 mg of depot... | 18 Years - 75 Years | Tata Memorial Hospital | |
| Functional Characterization of Thrombopoietin/cMPL Receptor Mutations in Myeloproliferative Neoplasia | NCT06246006 | Myeloproliferat... | Gene sequencing | 18 Years - 99 Years | Centre Hospitalier Universitaire de Nīmes | |
| Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors | NCT05450562 | Neoplasm | SAR444200 Atezolizumab | 18 Years - | Sanofi | |
| The Physical Exercise and Prostate Cancer Study | NCT00658229 | Prostate Cancer | Strength traini... | - 75 Years | Oslo University Hospital | |
| Overcoming Primary Resistance to Immunotherapy in Metastatic Melanoma | NCT05304546 | Malignant Melan... Metastatic Mela... Immunotherapy BRAF V600E Malignant Melan... | Pembrolizumab Encorafenib Binimetinib | 18 Years - | Sheba Medical Center | |
| Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy | NCT00270127 | Anemia Cancer Neoplasm | Epoetin alfa | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures | NCT01287013 | Infection Cancer Neoplasm Empyema Granuloma | Cone-beam compu... Conventional Co... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer | NCT04163900 | Biliary Tract C... | NUC-1031 Gemcitabine Cisplatin | 18 Years - | NuCana plc |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
